Central Depository Services (India) Limited (NSE:CDSL)

Verve Therapeutics Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	322.57	184.84	503.63	855.9	418.88
Short-Term Investments	-	2,135	766.88	1,251	1,391	1,858
Trading Asset Securities	-	7,229	5,551	4,139	6,115	3,987
Cash & Short-Term Investments	9,686	9,686	6,503	5,894	8,363	6,264
Cash Growth	48.95%	48.95%	10.33%	-29.52%	33.50%	43.12%
Accounts Receivable	-	678.97	783.64	460.75	520.79	485.16
Other Receivables	-	124.25	114.89	70.85	62.37	82.03
Receivables	-	803.98	899.07	532.18	583.81	567.96
Prepaid Expenses	-	354.1	187.68	68.74	62.02	39.29
Other Current Assets	-	178.98	396.07	62.81	65.05	67.48
Total Current Assets	-	11,023	7,986	6,558	9,073	6,939
Property, Plant & Equipment	-	4,116	3,135	2,734	860.22	784.05
Long-Term Investments	-	5,696	5,942	4,677	2,859	2,780
Other Intangible Assets	-	419.36	318.47	255.21	239.54	178.1
Long-Term Accounts Receivable	-	19.51	17.06	8.51	4.6	1.84
Long-Term Deferred Tax Assets	-	0.22	2.45	2.65	-	0.23
Other Long-Term Assets	-	346.04	415.73	336.74	218.13	155.77
Total Assets	-	21,621	17,816	14,572	13,256	10,840
Accounts Payable	-	368.58	280.43	196.17	105.86	126.99
Accrued Expenses	-	712.93	540.62	384.53	267.01	194.32
Current Portion of Leases	-	10.25	5.33	12.09	1.44	1.71
Current Income Taxes Payable	-	141.69	55.09	23.92	22.43	29.66
Current Unearned Revenue	-	8.98	7.44	6.96	2.6	1.65
Other Current Liabilities	-	1,925	1,512	1,218	1,349	1,226
Total Current Liabilities	-	3,167	2,400	1,842	1,748	1,580
Long-Term Leases	-	19.54	8.23	11.61	1.47	1.07
Long-Term Unearned Revenue	-	1.76	0.31	0.09	-	-
Long-Term Deferred Tax Liabilities	-	254.02	186.53	48.38	58.38	22.86
Other Long-Term Liabilities	-	45.94	39.31	28.95	26.06	3.37
Total Liabilities	-	3,583	2,745	2,000	1,893	1,640
Common Stock	-	2,090	1,045	1,045	1,045	1,045
Retained Earnings	-	15,529	13,606	11,087	9,895	7,727
Comprehensive Income & Other	-	-15.22	-17.82	5.11	-11.12	-
Total Common Equity	17,603	17,603	14,633	12,137	10,929	8,772
Minority Interest	-	435.23	438.44	434.08	433.84	427.83
Shareholders' Equity	18,039	18,039	15,072	12,571	11,363	9,200
Total Liabilities & Equity	-	21,621	17,816	14,572	13,256	10,840
Total Debt	29.79	29.79	13.56	23.71	2.91	2.78
Net Cash (Debt)	9,656	9,656	6,489	5,870	8,360	6,262
Net Cash Growth	48.80%	48.80%	10.55%	-29.78%	33.51%	43.18%
Net Cash Per Share	46.21	46.20	31.05	28.09	40.00	29.96
Filing Date Shares Outstanding	209	209	209	209	209	209
Total Common Shares Outstanding	209	209	209	209	209	209
Working Capital	-	7,856	5,585	4,716	7,325	5,359
Book Value Per Share	84.23	84.23	70.02	58.07	52.29	41.97
Tangible Book Value	17,184	17,184	14,315	11,882	10,690	8,594
Tangible Book Value Per Share	82.22	82.22	68.49	56.85	51.15	41.12
Buildings	-	2,987	2,398	650.76	650.76	649.44
Machinery	-	1,525	1,002	708.19	537.87	311.55
Construction In Progress	-	71.29	-	1,732	-	100.56

Source: S&P Global Market Intelligence. Standard template. Financial Sources.